Sudarshan Pharma IPO

Sudarshan Pharma IPO description - The company was established in 2008 as Sudarshan Specialty Chemsolve Private Limited and its name was changed to the current one in 2016. It markets pharmaceutical formulation & products in the Domestic and International markets through its own distribution network and sales force under its own brand. The company has a contract manufacturing agreement with four pharmaceutical companies. The company also supplies generic pharmaceutical formulation as – Make to order – for bulk supply to the hospital, Health Centre of Corporate, Municipality and exports.

Sudarshan Pharma supplies Active Pharmaceutical Ingredients (APIs), Intermediates Finished Dosage Formulations (FDFs) and Specialty Chemicals (SCs) in the domestic markets with a presence in 5 States. To develop its export business, the company is in the process of applying for 16 formulation registrations in countries like Ghana, Georgia, Cambodia, Myanmar, Nigeria, Kenya, Malaysia & MINA region.

The management is planning for business expansion by having its own state of the art manufacturing facility at Wada, near Mumbai, Maharashtra.

Sudarshan Pharma promoters – Mr Hemal V. Mehta & Mr Sachin V. Mehta
Sudarshan Pharma - Upcoming IPO details
Subscription Dates12 - 24 June 2019 (IPO canceled due to poor response)
IPO Price bandINR75 per share
Fresh issue 3,440,000 shares (INR25.80 crore)
Offer for sale Nil
Total IPO size3,440,000 shares (INR25.80 crore)
Minimum bid (lot size)1,600 shares
Face Value INR10 per share
Retail Allocation50%
Listing OnNSE Emerge SME platform
Use of funds
  • To set up a dedicated manufacturing facility for Pharmaceutical Business - INR12.50 crore
  • Distribution and Warehousing Centre‘s & Purchase of Corporate Office - INR4.50 crore
  • Additional Working Capital - INR5.25 crore
  • General Corporate Expenses - INR2.80 crore
  • Issue Expenses - INR0.75 crore
Sudarshan Pharma's consolidated financial performance (in INR crore)
FY2016FY2017FY20186M FY2019
Total revenue37.955.589.860.7
Total expenses37.855.388.858.7
Profit after tax0.090.160.741.46
Sudarshan Pharma Industries Contact Details

Sudarshan Pharma Industries Limited 
301, 3rd Floor, Aura Biplex
Above Kalyan Jewellers, S V Road
Borivali (West), Mumbai – 400 092

Phone: +91 22 242221111
Email: [email protected]

Sudarshan Pharma IPO Subscription Details
DaySubscription (no. of times)
Day 10.07
Day 20.14
Day 30.21
Day 40.43
Day 50.44
Day 60.44
Day 70.44
Day 80.45
Day 9
Sudarshan Pharma Valuation (For FY2018)

Earnings Per Share (EPS): INR2.90

Price/Earnings (P/E) ratio: 25.86

Return on Net Worth (RONW): 8.66%

Net Asset Value (NAV): INR18.10 per share

Registrar of Sudarshan Pharma IPO

Karvy Fintech Private Limited
Karvy Selenium Tower B, Plot 31-32,
Gachibowli, Nanakramguda,
Hyderabad – 500 032, Telangana

Phone: +91 40 6716 2222 
 +91 40 2343 1551 
[email protected]

Sudarshan Pharma IPO Allotment Status

Sudarshan Pharma IPO allotment status will be available on Karvy website. Click on this link to get allotment status.

Listing performance of Sudarshan Pharma

IPO Opening Date: 12 June 2019 (IPO canceled due to poor demand)

IPO Closing Date: 24 June 2019 (IPO canceled due to poor demand)

Listing Date: To be updated

Listing Price on NSE SME: To be updated

Closing Price on NSE SME: To be updated

One thought on “Sudarshan Pharma IPO

  • May 31, 2019 at 11:40 AM

    Strong financials backed by sound promoters. Worth taking a look.


Leave a Reply

Your email address will not be published. Required fields are marked *